Skip to main content
Skip to footer
Home
Home
About
Overview
Management Team
Board of Directors
Medical & Scientific Advisors
Pipeline
Overview
NP-120 (Ifenprodil)
NP-251 (Repirinast)
AP-188 (DMT)
Companies
Algernon NeuroScience
News & Media
News Releases
IR Calendar
Presentations
Videos/Articles
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEDAR
Governance
Contact
Financial Results
Investors
Investors
Overview
News & Events
Overview
News Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Annual General Meeting
Analysts
Stock Data
CSE:AGN
OTCQB:AGNPF
XFRA:AGW0
SEDAR
Governance
Overview
Board of Directors
Board Committees
Governance Documents
2022
FY 2022
Fiscal Year Ended Aug 31, 2022
Financial Statements
PDF
MD&A
PDF
Q3 2022
Quarter Ended May 31, 2022
Financial Statements
PDF
MD&A
PDF
Q2 2022
Quarter Ended Feb 28, 2022
Financial Statements
PDF
MD&A
PDF
Q1 2022
Quarter Ended Nov 30, 2022
Financial Statements
PDF
MD&A
PDF
Facebook
Twitter
LinkedIn
Email Alerts
Email Alerts
Contacts
RSS News Feed
